FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295088384> ?p ?o ?g. }

• W4295088384 endingPage "793" @default.
• W4295088384 startingPage "786" @default.
• W4295088384 abstract "The study aims to investigate the suppressing tumor-promoting effects via multi-anti-angiogenesis activity of the copper chelator (ammonium tetrathiomolybdate, TM) combined with lenvatinib for hepatocellular carcinoma.A total of 55 C57 mice were injected subcutaneously with Hepa1-6 hepatoma cell suspensions into the right posterior thigh. After 7 days, the subcutaneous tumors were formed, and the mice were randomly divided into five groups: TM (G1), Lenvatinib (G2), TM+Lenvatinib (G3), Control (G4), and Copper (II) Gluconate (G5). The copper concentrations in serum and tumors were measured at the predetermined time points. After 14 days of treatments, tumor weight and volumes were analyzed, histology was observed, and the expressions of vascular endothelial growth factor (VEGF) and microvessel density (MVD) in tumor tissues were measured by immunohistochemistry.The median concentration of copper in serum was 401.70, 469.40, and 665.35 μg/L in normal mice, in mice 7 days after implantation, and in the control group, respectively. The intratumoral copper concentrations were higher in G4 mice than in mice 7 days after implantation (P < 0.05). The serum concentration of copper was higher in G5 than all the other groups (P < 0.05; (G1, G2, and G3) vs. G4, P < 0.05; G1 vs. G2, P = 0.013; G2 vs. G3, P = 0.018; G1 vs. G3, P = 0.903. The intratumoral copper concentrations were 608.40, 980.00, 539.31, and 2938.90 μg/L in G1, G2, G3, and G5, respectively. The average tumor weight was 0.55, 0.44, 0.08, 1.37, and 3.11 in G1, G2, G3, G4, and G5, respectively. G5 vs. other groups, P < 0.05; (G1, G2, and G3) vs. G4, P < 0.05; G1 vs. G3, P < 0.05; G2 vs. G3, P < 0.05; G1 vs. G2, P > 0.05. Furthermore, the expression levels of VEGF were significantly lower in G1, G2, and G3 than in G4 and G5 (P < 0.05). A similar trend was observed for MVD in the five groups, but no significant difference was detected in G1 and G2.The study showed a significant positive correlation between tumor load and copper. Copper promotes tumor progression, but copper chelating suppresses tumor growth. The combination of TM with lenvatinib reduces tumor angiogenesis and improves the effect of antitumor treatment. These findings underlie the clinical application of combination therapy." @default.
• W4295088384 created "2022-09-10" @default.
• W4295088384 creator A5006157963 @default.
• W4295088384 creator A5013656851 @default.
• W4295088384 creator A5033033007 @default.
• W4295088384 creator A5042306963 @default.
• W4295088384 date "2023-04-01" @default.
• W4295088384 modified "2023-10-14" @default.
• W4295088384 title "Multitargeting Strategy Using Tetrathiomolybdate and Lenvatinib: Maximizing Antiangiogenesis Activity in a Preclinical Liver Cancer Model" @default.
• W4295088384 cites W1863396492 @default.
• W4295088384 cites W1876035649 @default.
• W4295088384 cites W1971837077 @default.
• W4295088384 cites W1985804036 @default.
• W4295088384 cites W1992112921 @default.
• W4295088384 cites W1992134233 @default.
• W4295088384 cites W1996990042 @default.
• W4295088384 cites W2002205398 @default.
• W4295088384 cites W2052480474 @default.
• W4295088384 cites W2052811525 @default.
• W4295088384 cites W2059320976 @default.
• W4295088384 cites W2059860479 @default.
• W4295088384 cites W2069421607 @default.
• W4295088384 cites W2076901898 @default.
• W4295088384 cites W2092108979 @default.
• W4295088384 cites W2093412095 @default.
• W4295088384 cites W2131217588 @default.
• W4295088384 cites W2136912351 @default.
• W4295088384 cites W2149499310 @default.
• W4295088384 cites W2151600653 @default.
• W4295088384 cites W2157567077 @default.
• W4295088384 cites W2176047031 @default.
• W4295088384 cites W2289095651 @default.
• W4295088384 cites W2319962899 @default.
• W4295088384 cites W2411621181 @default.
• W4295088384 cites W2532243786 @default.
• W4295088384 cites W2533319884 @default.
• W4295088384 cites W2564477303 @default.
• W4295088384 cites W2601868035 @default.
• W4295088384 cites W2772948423 @default.
• W4295088384 cites W2787358630 @default.
• W4295088384 cites W2799897205 @default.
• W4295088384 cites W2883204623 @default.
• W4295088384 cites W2887846086 @default.
• W4295088384 cites W2892757136 @default.
• W4295088384 cites W2895658994 @default.
• W4295088384 cites W2901322776 @default.
• W4295088384 cites W2907978256 @default.
• W4295088384 cites W2947618428 @default.
• W4295088384 cites W2957907911 @default.
• W4295088384 cites W2973068330 @default.
• W4295088384 cites W2997891042 @default.
• W4295088384 cites W3001342088 @default.
• W4295088384 cites W3003002719 @default.
• W4295088384 cites W3015732624 @default.
• W4295088384 cites W3042744044 @default.
• W4295088384 cites W3206582181 @default.
• W4295088384 cites W3212006797 @default.
• W4295088384 cites W3213277274 @default.
• W4295088384 cites W4206815880 @default.
• W4295088384 cites W4232620598 @default.
• W4295088384 doi "https://doi.org/10.2174/1871520622666220907115027" @default.
• W4295088384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36082862" @default.
• W4295088384 hasPublicationYear "2023" @default.
• W4295088384 type Work @default.
• W4295088384 citedByCount "0" @default.
• W4295088384 crossrefType "journal-article" @default.
• W4295088384 hasAuthorship W4295088384A5006157963 @default.
• W4295088384 hasAuthorship W4295088384A5013656851 @default.
• W4295088384 hasAuthorship W4295088384A5033033007 @default.
• W4295088384 hasAuthorship W4295088384A5042306963 @default.
• W4295088384 hasBestOaLocation W42950883842 @default.
• W4295088384 hasConcept C126322002 @default.
• W4295088384 hasConcept C134018914 @default.
• W4295088384 hasConcept C142724271 @default.
• W4295088384 hasConcept C167734588 @default.
• W4295088384 hasConcept C185592680 @default.
• W4295088384 hasConcept C204232928 @default.
• W4295088384 hasConcept C2776231280 @default.
• W4295088384 hasConcept C2776264508 @default.
• W4295088384 hasConcept C2776436680 @default.
• W4295088384 hasConcept C2777025900 @default.
• W4295088384 hasConcept C2778019345 @default.
• W4295088384 hasConcept C2778695046 @default.
• W4295088384 hasConcept C2780394083 @default.
• W4295088384 hasConcept C502942594 @default.
• W4295088384 hasConcept C71924100 @default.
• W4295088384 hasConceptScore W4295088384C126322002 @default.
• W4295088384 hasConceptScore W4295088384C134018914 @default.
• W4295088384 hasConceptScore W4295088384C142724271 @default.
• W4295088384 hasConceptScore W4295088384C167734588 @default.
• W4295088384 hasConceptScore W4295088384C185592680 @default.
• W4295088384 hasConceptScore W4295088384C204232928 @default.
• W4295088384 hasConceptScore W4295088384C2776231280 @default.
• W4295088384 hasConceptScore W4295088384C2776264508 @default.
• W4295088384 hasConceptScore W4295088384C2776436680 @default.
• W4295088384 hasConceptScore W4295088384C2777025900 @default.
• W4295088384 hasConceptScore W4295088384C2778019345 @default.
• W4295088384 hasConceptScore W4295088384C2778695046 @default.

• next